Here are the 10-Q quarterly reports from Harrow, Inc. 11.875% Senior Notes due 2027 (HROWM) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HROWM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HROWM filings page.
Harrow, Inc. reported softer results for the quarter ended March 31, 2026. Total revenues were $44.2 million, down from $47.8 million a year earlier, as branded product sales grew but compounding revenues declined sharply, including the prior discontinuation of Klarity-C.
Branded revenue rose to $30.7 million, led by VEVYE at $20.9 million, while IHEEZO sales fell. Compounding revenue dropped to $13.5 million. Higher selling, general and administrative spending and increased R&D pushed the net loss to $27.6 million, compared with $17.8 million in the prior-year quarter.
Harrow ended the quarter with $94.6 million in cash and cash equivalents, helped by issuing an additional $50 million of 8.625% Senior Notes due 2030, bringing total notes payable, net, to $292.1 million. Operating cash flow swung to an outflow of $9.0 million from an inflow of $19.7 million a year earlier.